ARS Pharmaceuticals, Inc. (SPRY)

ARS Pharmaceuticals Revenue

ARS Pharmaceuticals had revenue of $22.68M in the quarter ending March 31, 2026, with 184.47% growth. This brings the company's revenue in the last twelve months to $98.99M, up 1.92% year-over-year. In the year 2025, ARS Pharmaceuticals had annual revenue of $84.28M, down -5.46%.

• Revenue (ttm): $98.99M
• Revenue Growth: +1.92%
• P/S Ratio: 7.97
• Revenue / Employee: $622,553
• Employees: 159
• Market Cap: 788.47M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	84.28M	-4.87M	-5.46%
Dec 31, 2024	89.15M	89.12M	297,063.33%
Dec 31, 2023	30.00K	-1.29M	-97.72%
Dec 31, 2022	1.32M	-4.19M	-76.10%
Dec 31, 2021	5.51M	-12.33M	-69.13%

Data Source: S&P Global Market Intelligence Last updated: Mar 9, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 21, 2026

Data Sources Report a data error